Presenting Author: O. Venediktova
Free Paper Session 25: Vasc Disease and Diabetic Ret 7 Session
Date: Sat Sep 2016
Time: 14:30:00 - 16:00:00
Room: Auditorium 15
PURPOSE: To evaluate changes in the eye of patients after cardiac surgery using a cardiopulmonary bypass.SETTING: P.L. Shupik National Medical Academy of Postgraduate Education, SI “The Heart Institute by the Ministry of Health of Ukraine”, 'Centre of eye microsurgery'METHODS: We examined 15 patients (30 eyes) 7 men and 8 women. The average age of patients was 57 +/ 1.5 years. All patients were diagnosed coronary artery disease with varying degree of obliteration of the coronary arteries. In 5 patients had mixed pathology combined with aortic or mitral valve insufficiency and 1 patient had an aortic aneurysm . All patients were examined by ophthalmologist before surgery which included general ophthalmologic research methods and additional methods the study of light sensitivity using computer perimetry, the analysis of caliber, optical coherence tomography (OCT) with determination of the retinal nerve fiber layer (RNFL) . Patients were performed cardiac surgery using cardiopulmonary bypass, conducted in 9 patients isolated coronary artery bypass grafting (CABG), in 2 – in combination with replacement of the aortic valve and in 3 mitral valve, in 1 patient in combination with the removal of an aortic aneurysm. All patients were examined on the second day after surgery in intensive care unit. Review included measurement of intraocular pressure (IOP) and fundus examination indirect ophthalmoscope in mydriasis conditions. 5 days after surgery performed visual acuity, computer perimetry and OCT.RESULTS: At the examination before cardiac surgery were found the initial cataract of 12 eyes (40%), 4 (13.3%) immature cataract, 16 eyes (53.3%) hypertensive retinal angiopathy. At 2 days after cardiac surgery patients were found in the fundus significant expansion venules 5 eyes (16.6%), edema of disk optic nerve 1 eye (3%), single perypapilar hemorrhage 4 eyes (13.3%), increased IOP 3 eyes (10%). After 5 days there was normalization of IOP, in 3 eyes (10%) showed a reduction in visual acuity, 4 eyes (13.3%) decrease in central light sensivity, in 4 eyes (13.3%) – decrease RNFL in the nasal and temporal segments of the data OCT .CONCLUSIONS: In the early period after cardiac surgery using cardiopulmonary bypass were discovered ophthalmologic complications in a rise in intraocular pressure, reduced visual acuity, retinal vascular caliber changes and perypapilyar hemorrhage. To assess the level of lesions and the risk of further complications of ophthalmic needed further and deep study on a larger group of patients and in long term followup.
Please enter authors name.
Please select from list below.
H. Arifoglu - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
The effect of anti-VEGF and dexamethasone implant treatment on retinal nerve fiber layer in branch retinal vein occlusion
G. Barcat Angelelli - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Gloucestershire eye study: Retinal vein occlusion real world visual acuity outcomes with ranibizumab treatment
F. Fabro - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
OCT angiography evaluation of macular anomalies in retinal branch vein occlusion
A. Giocanti - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Impact of serous retinal detachment on functional and anatomical outcomes in patients with diabetic macular edema treated by ranibizumab
M. Gunay - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Effect of single intravitreal bevacizumab injection on ophthalmic arterial blood flow in retinopathy of prematurity
A. Korol - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
One year outcomes with intravitreal aflibercept for choroidal neovascularization associated with angioid streaks: a pilot study
M. Larsen - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Evaluation of the potential to skip visits in Year 2 in patients treated with intravitreal ranibizumab 0.5 mg for branch and central retinal vein occlusion: evidence from the BRIGHTER and CRYSTAL studies
A. Mandavia - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Real world study of intravitreal dexamethasone 0.7mg implant(s) in patients with macular oedema in a district general hospital, UK
J. Mones - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Top 10 pearls from the SHORE study: ranibizumab treatment for branch and central retinal vein occlusion
Z. Shalchi - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Is HbA1c a predictor of response to ranibizumab therapy in diabetic macular edema?
A. Tufail - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Automated diabetic retinopathy image assessment softwares: diagnostic accuracy and cost effectiveness compared to human graders
O. Venediktova - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Changes in the eyes in patients after cardiac surgery using cardiopulmonary bypass
J. Xavier Neves - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Long term results in patients with central retinal vein occulsion treated with bevacizumab: risk of secondary neovascularization
R. Zainullin - Free Paper Session 25: Vasc Disease and Diabetic Ret 7 2016-09-10 -
Features of distribution of macular pigment in diabetic macular edema